Market Research Future (MRFR) anticipates that the Nerve Stimulators Market size can record a decent growth rate of 9.7% between 2017 and 2023 (assessment period). The nerve stimulators market size is also projected to touch USD 10,978.5 Million till 2023.
The COVID-19 outbreak has left a debilitating impact on the healthcare sector as well as the medical device industry, given the temporary shutdown of manufacturing facilities and weakened demand. Even as the world is trying to curb the spread of SARS-CoV-2, top companies are striving to bolster their supply chains and accelerate their operations to control further losses. Also, the social distancing practice prevalent worldwide has encouraged patients to go for devices that can be used at home, which bolsters the need for various types of nerve stimulators. Healthcare professional are now offering consultation via video conferencing as well as phone calls, in view of the spread of the pandemic. This is more than likely to benefit the nerve stimulators market in the years to follow.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5258
Some of key the players in the market are Boston Scientific Corporation, Cochlear Ltd, Medtronic plc, St Jude Medical, Inc., Cyberonics, Inc., Aleva Neurotherapeutics SA, NeuroPace, Inc, and others.
The Americas dominate the nerve stimulators market owing to the rising prevalence of chronic diseases, a well-developed technology, high healthcare expenditure, and the presence of the leading players. According to a study published in Drug and Alcohol Dependence journal in 2017, more than 100 million adult Americans are living with chronic pain. Chronic low back pain and headaches are the most commonly diagnosed conditions. It is also stated that conditions are more prevalent in women than men i.e. 34.3% in women, and 26.7% in men in the U.S.
Europe holds the second position in the nerve stimulators market. It is expected that the support provided by the government bodies for research & development, along with a well-developed technology drives the market in the European region.
Asia Pacific region is projected to be the fastest growing region during the forecast period. Increasing need for cost-effective nerve stimulators, rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific region.
The Middle East and Africa hold the least share in the market owing to the presence of poor and slow developing countries, especially, in the African region.
The global nerve stimulators market is segmented on the basis of type, application, and end-users.
On the basis of the type, the market is segmented into deep brain stimulator (DBS), vagus nerve stimulator (VNS), and spinal cord stimulator (SCS).
On the basis of the application, the market is classified as chronic pain, depression, dystonia, epilepsy, Parkinson's disease, and others.
On the basis of the end -users, the market is segmented into ambulatory surgical centers, hospital & clinics, and trauma centers.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nerve-stimulator-market-5258